Security record · archived quarter
AGIO
Agios Pharmaceuticals, Inc. · Healthcare · Biotechnology
15Tracked holders
0Δ holders
21.02MShares held
$699.20MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +2.4% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 1.91M | $63.34M | n/a | n/a |
| Q2 2026 | 89 | +3 | 38.62M | $1.43B | +11 | −8 |
| Q1 2026 | 89 | 0 | 33.63M | $1.14B | +5 | −5 |
| Q4 2025 | 89 | -2 | 38.17M | $1.04B | n/a | −2 |
| Q3 2025 | 19 | +2 | 22.49M | $902.53M | +2 | −1 |
| Q2 2025 | 15 | 0 | 21.02M | $699.20M | n/a | n/a |
| Q1 2025 | 12 | -1 | 9.99M | $292.81M | n/a | −1 |
| Q4 2024 | 13 | +2 | 10.10M | $332.03M | +2 | n/a |
| Q3 2024 | 10 | 0 | 7.27M | $323.20M | n/a | n/a |
| Q2 2024 | 10 | n/a | 7.12M | $306.93M | n/a | n/a |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 5.68M | n/a | $188.98M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 4.83M | n/a | $160.77M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 3 | T. Rowe Price ✦ | 2.27M | -1.2% | $75.64M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passive) | 1.95M | -20.4% | $64.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.41M | +0.8% | $46.76M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 1.08M | +25.2% | $35.97M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Fisher Asset Management ✦ | 877.54K | -8.5% | $29.19M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 791.00K | +6.5% | $26.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Marshall Wace ✦ | 684.67K | +31.4% | $22.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 596.20K | +7.5% | $19.83M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Wellington Management ✦ | 422.13K | +1625.7% | $14.04M | 0.0% | ▲ Add | 5 | SEC ↗ ×7 |
| 12 | Millennium Management ✦ | 300.20K | +465.6% | $9.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 96.90K | +88.2% | $3.21M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 14 | Fidelity (FMR) ✦ | 18.59K | n/a | $618,357 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | Norges Bank ✦ (passive) | 6.76K | -91.3% | $224,705 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 231 holders, 62.89M shares, $1.99B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API